COOPERATE Trial Profile
{"Image DocumentName": "COOPERATE Trial Profile", "Image ImageDescription": "336 patients screened. 35 excluded 10 needed immediate dialysis 25 no consent. 301 took part in 18-week run-in. 38 excluded 24 dry cough 1 angioedema 1 skin rash. 263 randomly allocated. 89 losartan and placebo. 86 trandolapril and placebo. 88 losartan and trandolapril. 3 lost in follow-up 1 moved away 2 discontinuation. 1 lost in follow-up (discontinuation) 3 lost in follow-up 1 protocol invalidation 2 discontinuation. 86 could be analyzed for primary endpoint. 85 could be analyzed for primary endpoint. 85 could be analyzed for primary endpoint. Nakao N, Yoshimura A, Morita H, Takada M, Kayano T, Ideura T. Lancet. 2003;361(9352):", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}